Published in BMC Health Serv Res on June 21, 2012
Benchmarking and audit of breast units improves quality of care. Facts Views Vis Obgyn (2013) 0.77
Indicators to assess the quality of programs to prevent occupational risk for tuberculosis: are they feasible? Rev Lat Am Enfermagem (2016) 0.75
The quality of health care delivered to adults in the United States. N Engl J Med (2003) 50.33
Weighted kappa: nominal scale agreement with provision for scaled disagreement or partial credit. Psychol Bull (1968) 20.58
Influence of delay on survival in patients with breast cancer: a systematic review. Lancet (1999) 13.10
Results of the National Initiative for Cancer Care Quality: how can we improve the quality of cancer care in the United States? J Clin Oncol (2006) 5.40
How many patients are necessary to assess test performance? JAMA (1990) 3.74
Developing a system to assess the quality of cancer care: ASCO's national initiative on cancer care quality. J Clin Oncol (2004) 2.52
Decreasing women's anxieties after abnormal mammograms: a controlled trial. J Natl Cancer Inst (2004) 1.90
Quality of health care for women: a demonstration of the quality assessment tools system. Med Care (2003) 1.66
Quality indicators in breast cancer care. Eur J Cancer (2010) 1.46
National Quality Measures for Breast Centers (NQMBC): a robust quality tool: breast center quality measures. Ann Surg Oncol (2009) 1.12
How to limit the burden of data collection for Quality Indicators based on medical records? The COMPAQH experience. BMC Health Serv Res (2008) 1.06
A quality review of the timeliness of breast cancer diagnosis and treatment in an integrated breast center. J Am Coll Surg (2010) 0.99
The Experience of Waiting for Diagnosis After an Abnormal Mammogram. Breast J (1999) 0.98
Satisfaction and anxiety for women during investigation of an abnormal screening mammogram. Breast Cancer Res Treat (2002) 0.97
Breast Cancer Screening: Women's Experiences of Waiting for Further Testing. Oncol Nurs Forum (2007) 0.92
The patient's perspective of the quality of breast cancer care. The development of an instrument to measure quality of care through focus groups and concept mapping with breast cancer patients. Eur J Cancer (2007) 0.92
Optimizing the quality of breast cancer care at certified german breast centers: a benchmarking analysis for 2003-2009 with a particular focus on the interdisciplinary specialty of radiation oncology. Strahlenther Onkol (2011) 0.91
Measuring the quality of breast cancer care in women. Evid Rep Technol Assess (Summ) (2004) 0.89
Suitability of three indicators measuring the quality of coordination within hospitals. BMC Health Serv Res (2010) 0.87
Many quality measurements, but few quality measures assessing the quality of breast cancer care in women: a systematic review. BMC Cancer (2006) 0.84
[The COMPAQH project: researches on quality indicators in hospitals]. Rev Epidemiol Sante Publique (2008) 0.81
Summary version of the Standards, Options and Recommendations for nonmetastatic breast cancer (updated January 2001). Br J Cancer (2003) 0.80
Enhancing the quality of care for patients with breast cancer: seven years of experience with a Dutch auditing system. Eur J Surg Oncol (2011) 0.80
[Provider delays among patients with breast cancer in a Regional Cancer Care Network: feasibility of personal care schedule]. Bull Cancer (2004) 0.78
[Patients' experiences--indications for treatment quality in breast cancer surgery]. Ugeskr Laeger (2006) 0.77
Sequential adjuvant epirubicin-based and docetaxel chemotherapy for node-positive breast cancer patients: the FNCLCC PACS 01 Trial. J Clin Oncol (2006) 4.87
Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial. Lancet (2007) 4.81
A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Med (2009) 4.13
Trastuzumab for patients with axillary-node-positive breast cancer: results of the FNCLCC-PACS 04 trial. J Clin Oncol (2009) 2.88
Early tracheotomy versus prolonged endotracheal intubation in unselected severely ill ICU patients. Intensive Care Med (2008) 2.57
6 months versus 12 months of adjuvant trastuzumab for patients with HER2-positive early breast cancer (PHARE): a randomised phase 3 trial. Lancet Oncol (2013) 2.39
Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review. Breast Cancer Res Treat (2011) 1.89
Barriers to staff adoption of a surgical safety checklist. BMJ Qual Saf (2011) 1.74
Life-threatening sepsis associated with adjuvant doxorubicin plus docetaxel for intermediate-risk breast cancer. JAMA (2005) 1.68
Concurrent administration of adjuvant chemotherapy and radiotherapy after breast-conserving surgery enhances late toxicities: long-term results of the ARCOSEIN multicenter randomized study. Int J Radiat Oncol Biol Phys (2006) 1.60
Efficacy of trastuzumab in routine clinical practice and after progression for metastatic breast cancer patients: the observational Hermine study. Oncologist (2010) 1.52
Randomized multicentric study of perioperative chemotherapy with mitoxantrone in early breast cancer. Ann Surg Oncol (2003) 1.46
Risk factors for Gram-negative bacterial infections in febrile neutropenia. Haematologica (2005) 1.44
Outcome of critically ill allogeneic hematopoietic stem-cell transplantation recipients: a reappraisal of indications for organ failure supports. J Clin Oncol (2005) 1.40
Multicenter phase II trial of neoadjuvant therapy with trastuzumab, docetaxel, and carboplatin for human epidermal growth factor receptor-2-overexpressing stage II or III breast cancer: results of the GETN(A)-1 trial. J Clin Oncol (2007) 1.27
SAPS II revisited. Intensive Care Med (2005) 1.16
Precision of composite performance scores: weighting systems impact the results. Med Care (2013) 1.07
Randomized trial comparing six versus three cycles of epirubicin-based adjuvant chemotherapy in premenopausal, node-positive breast cancer patients: 10-year follow-up results of the French Adjuvant Study Group 01 trial. J Clin Oncol (2003) 1.06
How to limit the burden of data collection for Quality Indicators based on medical records? The COMPAQH experience. BMC Health Serv Res (2008) 1.06
[For a coordination of the supportive care for people affected by severe illnesses: proposition of organization in the public and private health care centres]. Bull Cancer (2004) 1.03
[Standards, options and recommendations for nutritional support in bone marrow transplant patients]. Bull Cancer (2002) 1.01
Cancer screening in France: subjects' and physicians' attitudes. Cancer Causes Control (2007) 0.99
Frequency of cytochrome P450 2C9 allelic variants in the Chinese and French populations. Fundam Clin Pharmacol (2003) 0.98
Prevention of intravascular catheter-related infection with newer chlorhexidine-silver sulfadiazine-coated catheters: a randomized controlled trial. Intensive Care Med (2004) 0.98
Designing adverse event prevention programs using quality management methods: the case of falls in hospital. Int J Qual Health Care (2002) 0.98
Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early-stage breast cancer: final results of the ARCOSEIN trial. J Clin Oncol (2007) 0.96
Decision-making and breast cancer clinical trials: how experience challenges attitudes. Contemp Clin Trials (2007) 0.93
A phase III randomized trial comparing adjuvant concomitant chemoradiotherapy versus standard adjuvant chemotherapy followed by radiotherapy in operable node-positive breast cancer: final results. Int J Radiat Oncol Biol Phys (2006) 0.92
Protein expression, survival and docetaxel benefit in node-positive breast cancer treated with adjuvant chemotherapy in the FNCLCC-PACS 01 randomized trial. Breast Cancer Res (2011) 0.91
Nutritional risk factors in planned oncologic surgery: what clinical and biological parameters should be routinely used? World J Surg (2009) 0.90
Relationship between longitudinal continuity of primary care and likelihood of death: analysis of national insurance data. PLoS One (2013) 0.90
Is parenteral nutrition guilty? Intensive Care Med (2003) 0.84
Clinical and economic impact of malnutrition per se on the postoperative course of colorectal cancer patients. Clin Nutr (2012) 0.83
Method for developing national quality indicators based on manual data extraction from medical records. BMJ Qual Saf (2012) 0.83
[Standards, Options and Recommendations 2005 for a good practice in enteral nutrition in oncology (summary report.)]. Bull Cancer (2006) 0.82
Factors associated with the length of stay of patients discharged from emergency department in France. Eur J Emerg Med (2015) 0.82
Indwelling time and risk of infection of dialysis catheters in critically ill cancer patients. Intensive Care Med (2005) 0.81
Main barriers to effective implementation of stroke care pathways in France: a qualitative study. BMC Health Serv Res (2014) 0.81
[Safety and efficacy of bevacizumab combined with taxanes in the first-line treatment of metastatic breast cancer: ATHENA study-France]. Bull Cancer (2012) 0.81
Impact of organised programs on colorectal cancer screening. BMC Cancer (2008) 0.80
Constructing a composite quality score for the care of acute myocardial infarction patients at discharge: impact on hospital ranking. Med Care (2011) 0.79
Phase II study of an oxaliplatin/vinorelbine combination in patients with anthracycline- and taxane-pre-treated metastatic breast cancer. Anticancer Drugs (2006) 0.79
Does concurrent radiochemotherapy affect cosmetic results in the adjuvant setting after breast-conserving surgery? Results of the ARCOSEIN multicenter, Phase III study: patients' and doctors' views. Int J Radiat Oncol Biol Phys (2007) 0.78
[Can children visit their relatives in an adult ICU?]. Bull Cancer (2007) 0.78
Contribution of the ethics committee of the French Intensive Care Society to describing a scenario for implementing organ donation after Maastricht type III cardiocirculatory death in France. Ann Intensive Care (2012) 0.78
The role of calling EMS versus using private transportation in improving the management of stroke in France. Prehosp Emerg Care (2013) 0.77
[Physical activity and cancer survival]. Bull Cancer (2012) 0.77
[High and low-risk febrile neutropenic patients]. Presse Med (2004) 0.75
Treatment patterns, clinical outcomes and health care costs associated with HER2-positive breast cancer with central nervous system metastases: a French multicentre observational study. BMC Health Serv Res (2013) 0.75
Impacts of organizational context on quality improvement: don't forget internal management! Am J Med Qual (2013) 0.75
Are urokinase rinses needed to reduce catheter-related bloodstream infections when standard preventive guidelines are observed? J Clin Oncol (2008) 0.75
[Cancer networks]. Bull Cancer (2002) 0.75
Hospital performance based on treatment delays: comparison of ranking methods. BMJ Qual Saf (2013) 0.75
Assessment of care by breast cancer patients participating or not participating in a randomized controlled trial: a report with the Patients' Committee for Clinical Trials of the Ligue Nationale Contre le Cancer. J Clin Oncol (2007) 0.75
Symptom-to-needle times in ST-segment elevation myocardial infarction: shortest route to a primary coronary intervention facility. Arch Cardiovasc Dis (2013) 0.75
Gemcitabine and epirubicin in patients with metastatic breast cancer: a phase I/II study. Breast (2006) 0.75
[Surgery remains the first weapon against cancer: surgery in French cancer plan. The proposals of the group of French oncologists]. Bull Cancer (2002) 0.75
[Meningitis caused by Enterococcus faecalis during disseminated anguilluliasis]. Presse Med (2006) 0.75